151 related articles for article (PubMed ID: 7918131)
1. Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina.
Holdright DR; Sparrow JL; Wright CL; Steiner J; Fox KM
Cardiovasc Drugs Ther; 1994 Apr; 8(2):193-7. PubMed ID: 7918131
[TBL] [Abstract][Full Text] [Related]
2. An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group.
Leung JM; Stanley T; Mathew J; Curling P; Barash P; Salmenpera M; Reves JG; Hollenberg M; Mangano DT
Anesth Analg; 1994 Mar; 78(3):420-34. PubMed ID: 7818622
[TBL] [Abstract][Full Text] [Related]
3. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine.
Mangano DT; Miao Y; Tudor IC; Dietzel C; ;
J Am Coll Cardiol; 2006 Jul; 48(1):206-14. PubMed ID: 16814669
[TBL] [Abstract][Full Text] [Related]
4. Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat.
Galiñanes M; Mullane KM; Bullough D; Hearse DJ
Circulation; 1992 Aug; 86(2):598-608. PubMed ID: 1638725
[TBL] [Abstract][Full Text] [Related]
5. Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
Anesthesiology; 1995 Oct; 83(4):658-73. PubMed ID: 7574044
[TBL] [Abstract][Full Text] [Related]
6. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
Newman MF; Ferguson TB; White JA; Ambrosio G; Koglin J; Nussmeier NA; Pearl RG; Pitt B; Wechsler AS; Weisel RD; Reece TL; Lira A; Harrington RA;
JAMA; 2012 Jul; 308(2):157-64. PubMed ID: 22782417
[TBL] [Abstract][Full Text] [Related]
7. Effect of acadesine on myocardial ischaemia in patients with coronary artery disease.
de Jonge R; Macleod DC; Suryapranata H; van Es GA; Friedman J; Serruys PW; de Jong JW
Eur J Pharmacol; 1997 Oct; 337(1):41-4. PubMed ID: 9389379
[TBL] [Abstract][Full Text] [Related]
8. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group.
Mangano DT
JAMA; 1997 Jan 22-29; 277(4):325-32. PubMed ID: 9002496
[TBL] [Abstract][Full Text] [Related]
9. Effects of infusion of L-arginine on exercise-induced myocardial ischemic ST-segment changes and capacity to exercise of patients with stable angina pectoris.
Kobayashi N; Nakamura M; Hiramori K
Coron Artery Dis; 1999 Jul; 10(5):321-6. PubMed ID: 10421972
[TBL] [Abstract][Full Text] [Related]
10. Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart.
Galiñanes M; Bullough D; Mullane KM; Hearse DJ
Circulation; 1992 Aug; 86(2):589-97. PubMed ID: 1638724
[TBL] [Abstract][Full Text] [Related]
11. Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group.
Menasché P; Jamieson WR; Flameng W; Davies MK
J Thorac Cardiovasc Surg; 1995 Oct; 110(4 Pt 1):1096-106. PubMed ID: 7475138
[TBL] [Abstract][Full Text] [Related]
12. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
13. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Borer JS; Fox K; Jaillon P; Lerebours G;
Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
[TBL] [Abstract][Full Text] [Related]
14. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of atrial natriuretic peptide on exercise-induced myocardial ischemia in patients with stable effort angina pectoris.
Lai CP; Egashira K; Tashiro H; Narabayashi H; Koyanagi S; Imaizumi T; Takeshita A
Circulation; 1993 Jan; 87(1):144-51. PubMed ID: 8419001
[TBL] [Abstract][Full Text] [Related]
16. Acadesine: a unique cardioprotective agent for myocardial ischemia.
Nawarskas JJ
Heart Dis; 1999; 1(4):255-60. PubMed ID: 11720632
[TBL] [Abstract][Full Text] [Related]
17. Acadesine improves surgical myocardial protection with blood cardioplegia in ischemically injured canine hearts.
Vinten-Johansen J; Nakanishi K; Zhao ZQ; McGee DS; Tan P
Circulation; 1993 Nov; 88(5 Pt 2):II350-8. PubMed ID: 8222178
[TBL] [Abstract][Full Text] [Related]
18. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
19. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits.
Burckhartt B; Yang XM; Tsuchida A; Mullane KM; Downey JM; Cohen MV
Cardiovasc Res; 1995 May; 29(5):653-7. PubMed ID: 7606753
[TBL] [Abstract][Full Text] [Related]
20. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
